Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2026-01-02 @ 10:03 AM
Study NCT ID:
NCT04826393
Status:
COMPLETED
Last Update Posted:
2025-10-22
First Post:
2021-03-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
ASP8374 + Cemiplimab in Recurrent Glioma
Sponsor:
Dana-Farber Cancer Institute